Cancer Technologies

Overview

At the Wallace H. Coulter Department of Biomedical Engineering, our Cancer Technologies research area is focused on developing next-generation tools to fight cancer.

Our teams are innovating in cancer detection, minimally invasive surgery, and targeted therapies, working in close collaboration with the Winship Cancer Institute at Emory University and Children’s Healthcare of Atlanta. Our research spans a wide array of cancers, including leukemia, breast, lung, pancreatic, ovarian, glioblastoma, head and neck, colon, and prostate cancers.

Research Focus

We are engineering new solutions to tackle cancer at every stage, from diagnosis to treatment, including:  

• Molecular and Cellular Imaging: Developing contrast agents for precise cancer imaging
• Nanoparticle Drug Delivery: Targeted therapies to deliver drugs directly to tumors
• Robotic and Minimally Invasive Surgery: Advanced instrumentation for precision treatment
• Cancer Immunotherapy: Engineering immune responses and tumor environments
• Synthetic Biology: Designing cell-based therapies for customized interventions
• Biomarker Discovery: Creating algorithms for personalized cancer diagnostics

Application Areas

• Early Detection Technologies: Improving outcomes through timely diagnosis
• Minimally Invasive Treatment: Reducing surgical risk and improving recovery
• Targeted Therapies: Enhancing effectiveness while minimizing side effects
• Personalized Medicine: Tailoring treatment based on individual tumor profiles
• Pediatric Cancer Innovations: Addressing unique challenges in childhood cancers